Table 2:

Description of the demonstration database (7 cases imaged at both field strengths): lesion type, BI-RADS designation, age at imaging, time between imaging at the two field strengths, maximum lesion diameter (radiomic feature S4) as extracted from imaging at each field strength, and voxel resolution at each field strength. As available from radiological reports, additional information is given in the lesion type field. ME represents mass-enhancement, while NMLE stands for non-mass-like enhancement.

Subject number	Lesion Type	BI- RADS	Age at imaging (years)	Time between imaging at the two field strengths (days)	Maximum lesion diameter (radio mic feature S4) (mm)		Voxel resolution (given as x × y × z, mm)
					1.5 T	3.0 T	1.5 T	3.0 T
1	Benign	2	48	90	60.0	74.3	0.71 × 0.71 × 2	0.75 × 0.75 × 1.6
2	Benign (amorphous calcifications, NMLE)	4	61	20	76.7	75.0	0.75 × 0.75 × 2	0.75 × 0.75 × 1.6
3	Benign (fibroepithelial lesion)	4	40	1	15.0	13.2	0.76 × 0.76 × 1.6	0.75 × 0.75 × 1.6
4	HR+/HER2− (pleomorphic calcifications, ME within NMLE)	6	42	11	87.6	91.9	0.75 × 0.75 × 2	0.75 × 0.75 × 1.6
5	HR+/HER2− (ME)	6	51	16	20.5	18.6	0.74 × 0.74 × 2	0.74 × 0.74 × 1.6
6	HR+/HER2− (ME)	6	35	2	24.3	21.2	0.76 × 0.76 × 2	0.60 × 0.60 × 1.6
7	HR+/HER2− (NMLE)	6	60	7	108.0	110.8	0.76 × 0.76 × 2	0.74 × 0.74 × 1.6